West Pharmaceutical Services Inc
WST· NYSE
Released Aug 1, 2016, after the close
10-Q filed Aug 1, 2016, 32 days after period end · 0000105770-16-000086
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $388.00M | $359.70M | $368.90M | $344.50M |
| Net Income | $44.70M | $27.80M | $37.60M | $30.20M |
| EPS Diluted | $0.60 |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $0.38 |
| $0.52 |
| $0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.